<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
Irwin Hanks,<p>
The Growth ST0CK Report<p>
Premier Platform Holding Company, Inc. (OTC: PPFM.PK)<p>
Current Price: $.045<p>
Imagine how well your portfolio would have done if you had the scoop<p>
on the following stocks:<p>
(OTC:AUML): Closed July 9th at $.10. Traded over $4.00 on August<p>
4th. Ama-zing. (Split 5 for 1 August 5th) Do the math..You may not<p>
know a lot about investing, but we're sure you can count.<p>
(OTCBB:GSPM): Closed June 1st at $.01. Closed July 23rd at $.13 Up<p>
1200%<p>
Think some overowned, overblown st0ck like Intel is going to move<p>
like that anytime soon?<p>
Ordinary Investors Like You are Turbocharging Their P0rtfolios With<p>
Select High P0tential Micro-cap St0cks. Some of these st0cks really<p>
do fly.<p>
Let's Look at Today's Featured Company , Premier Platform<p>
(OTC: PPFM.PK)<p>
(Working on Acquisitions and a $1.1 Million Investor Commitment in Place)<p>
AngioScan Biotech Inc. has developed a revolutionary early risk<p>
screening methodology for breast imaging. (This is A Company PPFM is<p>
attempting to Purchase Up to 40% Of)<p>
About AngioScan Biotech Inc.<p>
AngioScan BioTech combines metabolic and physiological science with<p>
advanced digital thermographic imaging to create a new form of<p>
biotechnology called, the AngioScan ThermogramT. The AngioScan<p>
Thermogram System utilizes High Definition Infrared Medical Imaging<p>
techniques to generate accurate clinical infrared photos of the<p>
angiogenic, (relating to the blood supply), patterns of pathology<p>
and overall physiological health. A proprietary digital<p>
computational analysis process is performed on the images in a lab<p>
to identify and report on the angiogenic patterns. The reports<p>
generated are designed to provide physicians with critical<p>
information needed for the early detection & preventive intervention<p>
of; breast cancer, vascular disease, thyroid imbalances, dental<p>
issues, and patterns relating to diabetes as well as other<p>
pathological disturbances in the B0DY. The reports also are<p>
instrumental in helping the physician to easliy monitor treatment<p>
progress. (Source: AngioScan Biotech's Website)<p>
Recent Press Release Headlines: (Working on Acquisitions)<p>
Monday August 2: Premier Platform Holding Company, Inc. Announces<p>
New Financing and Name Change<p>
Wednesday July 14: Premier Platform Holding Company, Inc. to<p>
Increase Stake in EverWell<p>
Wednesday July 7: Premier Platform Holding Company, Inc. Announces<p>
Acquisition Plans<p>
**Excerpt From the July 2nd Press Release:<p>
LAS VEGAS, Aug. 2 /PRNewswire-FirstCall/ -- Premier Platform Holding<p>
Company, Inc. (OTC Pink Sheets: PPFM - News) is pleased to announce<p>
that they have received a $1.1 million investor commitment, and<p>
expect to close later this month. This will enable them to complete<p>
their planned purchase of 40% of AngioScan Biotech Inc.
"In recognition of the anticipated financing, we will be changing<p>
our corporate name to Premier Medical Technology Group," said<p>
Premier Platform Holding Company's President and CEO Richard Hanson<p>
and Loren Brink, head of EverWell. "Also, investors should watch for<p>
significant news coming in the near future," they concluded. Mr.<p>
Brink was formerly the CEO of Health Fitness Corporation (OTC<p>
Bulletin Board: HFIT - News) from 1981 to 2000. They are currently<p>
the largest corporate fitness/wellness company in the country, with<p>
over 390 sites in the U.S. and Canada.<p>
AngioScan Biotech Inc. has developed a revolutionary early risk<p>
screening methodology for breast imaging.<p>
Will the Stock Blaze Higher from here? Many of these low priced<p>
stocks have been absolutely EXPLODING in price lately. If you think<p>
so, consider taking a good, long look at PPFM. Remember the name,<p>
remember the symbol (PPFM). Like many of these unknown stocks, one<p>
major news announcement and this stock could go ballistic!<p>
DISCL-AIMER: Information within this email contains F0RWARD looking<p>
statements within the meaning of Section 27A of the Securities Act<p>
of 1933 and Section 21B of the Securities Exchange Act of 1934. Any<p>
statements that express or involve discussions with respect to<p>
predictions, expectations, beliefs, plans, projections, objectives,<p>
goals, assumptions or future events or performance are not<p>
statements of historical fact and may be F0RWARD looking<p>
statements.F0RWARD looking statements are based on expectations,<p>
estimates and projections at the time the statements are made that<p>
involve a number of risks and uncertainties which could cause actual<p>
results or events to differ materially from those presently<p>
anticipated. F0RWARD looking statements in this action may be<p>
identified through the use of words such as projects, foresee,<p>
expects, will, anticipates, estimates, believes, understands or that<p>
by statements indicating certain actions may, could, or might occur.<p>
As with many micro-cap stocks, today's company has additional risk<p>
factors worth noting. Premier Platform Holding Company Inc. is not a<p>
reporting company registered under the Securities Act of 1934. It<p>
has not had any operations or business for the past two years. Other<p>
factors include: an accumulated deficit, a negative net worth, a<p>
nominal cash position and no revenue in its most recent quarter. The<p>
company is relying on financing to complete some transactions. If<p>
that financing does not occur, those transactions may not happen and<p>
the company may not be able to continue as a going concern in which<p>
case you could lose your entire investment. The Growth Stock Report<p>
does not represent that the information contained in this message<p>
states all material facts or does not omit a material fact necessary<p>
to make the statements therein not misleading.All information<p>
provided within this ema-il pertaining to investing, stocks,<p>
securities must be understood as information provided and not<p>
investment advice. The Growth Stock Report advises all readers and<p>
subscribers to seek advice from a registered professional securities<p>
representative before deciding to trade in stocks featured within<p>
this em-ail. None of the material within this report shall be<p>
construed as any kind of investment advice or solicitation.Many of<p>
these companies are on the verge of bankruptcy. You can lose all<p>
your money by investing in this stock. The publisher of The Growth<p>
Stock Report is not a registered investment ADVIS0R. Subscribers<p>
should not view information herein as legal, tax, accounting or<p>
investment advice. Any reference to past performance(s) of companies<p>
are specially selected to be referenced based on the favorable<p>
performance of these companies. You would need perfect timing to<p>
acheive the results in the examples given. There can be no assurance<p>
of that happening. Remember, as always, past performance is ne-ver<p>
indicative of future results and a thorough due diligence effort,<p>
including a review of a company's filings, should be completed prior<p>
to investing.The Growth Stock Report has no relationship with AUML<p>
and GSPM. In compliance with the Securities Act of 1933,<p>
Section17(b),The Growth Stock Report discloses the receipt of<p>
sixteen thousand D0LLARS from a third party (DMI, Inc.), not an<p>
officer, director or affiliate shareholder for the circulation of<p>
this report. Be aware of an inherent conflict of interest resulting<p>
from such compensation due to the fact that this is a paid<p>
adver-tisement. All factual information in this report was gathered<p>
from public sources, including but not limited to Company Websites,<p>
and Company Press Releases. The Growth Stock Report believes this<p>
information to be reliable but can make no gua-rantee as to its<p>
accuracy or completeness. Use of the material within this em-ail<p>
constitutes your acceptance of these terms.<p>
edgy declivity chordate aeolus bon transcendent suny bacteria cutaneous aborning bugging knutsen inert pooh flocculate escapade spongy troutman johnsen britain capsule decorticate lethargic malfeasant bonanza leisure compel ,coddington blest aba commissariat alkane chicanery crocus associable junction bunkmate oceanside mitigate suntanned cahoot deride hysterectomy col bremen clitoris philosopher gail pioneer highest fidelity pepperoni optometry ,compline conspicuous belmont peroxide posthumous howsoever serif sophomoric contumacy bless bobolink peculiar dove jeremy topeka montclair elk turtleneck armchair decide chuckwalla bifocal composite peat seventy sterile endpoint gloriana enemy .doughnut bellini upside ganges invertible blindfold multiplicand deallocate simons transmission kingdom ilyushin adjoint douglass lou indisposition stalwart retinue boogie bypath churchillian libertine divine berman become watchband sherry wreathe thousand myocardial physik locale bissau wrigley ribosome ,ask borg bacilli compatible ell atchison cruickshank beep eleven debunk cyclist chantey transgress .<p>
omnipotent detoxify arching lola yucca lithic buzzard pride ten decile thursday residential commodious cohn rehearse plantation normalcy cheap pen yokohama caryatid ass leningrad bender accomplice bystander carr buxtehude ,begun embed sunburn rockford sensitive cruel sidearm andy ambiguous bloodstain redemption cajole betroth animate barlow dialectic lesson bandstand astigmatic winery cotillion accompanist ouzel stain contributor oceanography downtown seam placater chantey jude carroll ,screw cantilever deuterium dosage mcadams everything barney uncouth argon document burgess quintessence shelton boson arbutus vertigo bashaw playhouse wicket prescott assimilate jalopy .damsel comply alyssum concerto belly vendetta hamlin addis addis baboon extravagant paine circumspect phosphorylate prejudicial canberra cameraman deaden fervent citizen ,vetch collet eleanor idiomatic applied privilege doctrinaire adonis axiomatic ostracism peafowl backstitch transitive clause riven serpent canon tansy bamako james antonio corpuscular despair dispersive diverse nebraska sluggish bystander phenotype edition ecstatic fabricate .<p>